It also had plans to start filling doses of its COVID vaccine in the continent as early as 2023. However, Moderna has not received any vaccine orders for Africa since 2022 amid waning demand ...
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...
A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for COVID vaccine technology that helped save millions of lives during the pandemic.
COVID-19 vaccine maker Moderna (NASDAQ:MRNA) announced Thursday that its plans to build a messenger RNA vaccine plant in Kenya are on hold as it weighs future demand for mRNA vaccines in Africa.
(Reuters) -Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in ...
Moderna claims it is due compensation for products manufactured after March 7 last year. But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid". The hearing ...
Shares of Moderna ... vaccine data is interesting. In his words, says the data suggests the vaccine could potentially work in industries outside of melanoma. He has a buy rating, price target ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
Also Read: Moderna’s Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial. “Given this, and in alignment with our strategic planning, Moderna believes it is prudent to pause its ...
Verizon has another price increase on the way. In an email to customers on Thursday, the company revealed a $5 per month price increase affecting plans tied to Apple Watch and other connected ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...